S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
pixel
pixel
pixel
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
pixel
pixel
pixel
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
pixel
pixel
pixel
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
pixel
pixel
pixel
NYSE:GMRE

Global Medical REIT Stock Forecast, Price & News

$14.82
-0.18 (-1.20 %)
(As of 09/24/2021 12:00 AM ET)
Add
Compare
Today's Range
$14.81
$15.09
50-Day Range
$14.82
$15.97
52-Week Range
$12.11
$16.07
Volume448,398 shs
Average Volume460,939 shs
Market Capitalization$951.40 million
P/E RatioN/A
Dividend Yield5.47%
Beta0.73
30 days | 90 days | 365 days | Advanced Chart
Receive GMRE News and Ratings via Email

Sign-up to receive the latest news and ratings for Global Medical REIT and its competitors with MarketBeat's FREE daily newsletter.


Global Medical REIT logo

About Global Medical REIT

Global Medical REIT, Inc. engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

2.66 out of 5 stars

Finance Sector

148th out of 1,331 stocks

Real Estate Investment Trusts Industry

26th out of 219 stocks

Analyst Opinion: 2.5Community Rank: 4.5Dividend Strength: 1.7Insider Behavior: 3.3Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Global Medical REIT (NYSE:GMRE) Frequently Asked Questions

Is Global Medical REIT a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Global Medical REIT in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Global Medical REIT stock.
View analyst ratings for Global Medical REIT
or view top-rated stocks.

What stocks does MarketBeat like better than Global Medical REIT?

Wall Street analysts have given Global Medical REIT a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Global Medical REIT wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Global Medical REIT's next earnings date?

Global Medical REIT is scheduled to release its next quarterly earnings announcement on Wednesday, November 3rd 2021.
View our earnings forecast for Global Medical REIT
.

How were Global Medical REIT's earnings last quarter?

Global Medical REIT Inc. (NYSE:GMRE) issued its quarterly earnings results on Tuesday, August, 3rd. The company reported $0.04 EPS for the quarter, missing the Zacks' consensus estimate of $0.22 by $0.18. Global Medical REIT had a net margin of 0.15% and a trailing twelve-month return on equity of 0.03%.
View Global Medical REIT's earnings history
.

How has Global Medical REIT's stock price been impacted by Coronavirus (COVID-19)?

Global Medical REIT's stock was trading at $12.41 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, GMRE shares have increased by 19.4% and is now trading at $14.82.
View which stocks have been most impacted by COVID-19
.

How often does Global Medical REIT pay dividends? What is the dividend yield for Global Medical REIT?

Global Medical REIT declared a quarterly dividend on Monday, September 13th. Investors of record on Friday, September 24th will be given a dividend of $0.205 per share on Friday, October 8th. This represents a $0.82 annualized dividend and a dividend yield of 5.53%. The ex-dividend date of this dividend is Thursday, September 23rd.
View Global Medical REIT's dividend history
.

Is Global Medical REIT a good dividend stock?

Global Medical REIT pays an annual dividend of $0.82 per share and currently has a dividend yield of 5.47%. GMRE has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Global Medical REIT does not yet have a strong track record of dividend growth. The dividend payout ratio of Global Medical REIT is 93.18%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, Global Medical REIT will have a dividend payout ratio of 75.93% in the coming year. This indicates that Global Medical REIT may not be able to sustain their current dividend.
View Global Medical REIT's dividend history.

What price target have analysts set for GMRE?

4 Wall Street analysts have issued 1-year target prices for Global Medical REIT's shares. Their forecasts range from $16.00 to $18.00. On average, they anticipate Global Medical REIT's share price to reach $17.25 in the next twelve months. This suggests a possible upside of 16.4% from the stock's current price.
View analysts' price targets for Global Medical REIT
or view top-rated stocks among Wall Street analysts.

Who are Global Medical REIT's key executives?

Global Medical REIT's management team includes the following people:
  • Jeffrey Mark Busch, Chairman, President & Chief Executive Officer
  • Danica Holley, Chief Operating Officer
  • Robert J. Kiernan, Chief Financial Officer & Treasurer
  • Alfonzo Leon, Chief Investment Officer
  • Allen E. Webb, Senior VP-SEC Reporting & Technical Accounting

What other stocks do shareholders of Global Medical REIT own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Medical REIT investors own include (PFG), INSYS Therapeutics (INSY), General Electric (GE), New Residential Investment (NRZ), AT&T (T), Big Lots (BIG), Square (SQ), Energy Transfer (ET), Medical Properties Trust (MPW) and AGNC Investment (AGNC).

When did Global Medical REIT IPO?

(GMRE) raised $130 million in an initial public offering on Wednesday, June 29th 2016. The company issued 13,000,000 shares at $10.00 per share. Wunderlich and Oppenheimer served as the underwriters for the IPO and BB&T Capital Markets, Compass Point and D.A. Davidson were co-managers.

What is Global Medical REIT's stock symbol?

Global Medical REIT trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMRE."

Who are Global Medical REIT's major shareholders?

Global Medical REIT's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (9.01%), BlackRock Inc. (7.25%), Aew Capital Management L P (4.67%), Prudential Financial Inc. (3.62%), Nuveen Asset Management LLC (3.54%) and American Century Companies Inc. (3.61%). Company insiders that own Global Medical REIT stock include Henry Cole, Jeffrey Busch and Ronald Marston.
View institutional ownership trends for Global Medical REIT
.

Which major investors are selling Global Medical REIT stock?

GMRE stock was sold by a variety of institutional investors in the last quarter, including Prudential Financial Inc., Nuveen Asset Management LLC, Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD, Kennedy Capital Management Inc., Millennium Management LLC, Psagot Investment House Ltd., Alliancebernstein L.P., and Meitav Dash Investments Ltd..
View insider buying and selling activity for Global Medical REIT
or view top insider-selling stocks.

Which major investors are buying Global Medical REIT stock?

GMRE stock was acquired by a variety of institutional investors in the last quarter, including Aew Capital Management L P, BlackRock Inc., Adelante Capital Management LLC, Sei Investments Co., State Street Corp, Russell Investments Group Ltd., Vanguard Group Inc., and Geode Capital Management LLC. Company insiders that have bought Global Medical REIT stock in the last two years include Henry Cole, Jeffrey Busch, and Ronald Marston.
View insider buying and selling activity for Global Medical REIT
or or view top insider-buying stocks.

How do I buy shares of Global Medical REIT?

Shares of GMRE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Global Medical REIT's stock price today?

One share of GMRE stock can currently be purchased for approximately $14.82.

How much money does Global Medical REIT make?

Global Medical REIT has a market capitalization of $951.40 million and generates $93.73 million in revenue each year. The company earns $-1,920,000.00 in net income (profit) each year or $0.88 on an earnings per share basis.

How many employees does Global Medical REIT have?

Global Medical REIT employs 22 workers across the globe.

What is Global Medical REIT's official website?

The official website for Global Medical REIT is www.globalmedicalreit.com.

Where are Global Medical REIT's headquarters?

Global Medical REIT is headquartered at 2 Bethesda Metro Center Suite 440, BETHESDA MD, 20814.

How can I contact Global Medical REIT?

Global Medical REIT's mailing address is 2 Bethesda Metro Center Suite 440, BETHESDA MD, 20814. The company can be reached via phone at (202) 524-6851 or via email at [email protected].


This page was last updated on 9/25/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.